New SCLC Biomarkers Enable Advances in Precision Medicine Approaches

A groundbreaking study published in Volume 15 of Oncotarget on October 11, 2024, titled 'Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC' showcases pivotal advancements in the fight against small cell lung cancer (SCLC).